e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cystic fibrosis: clinical and laboratory studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of disease knowledge in children with cystic fibrosis and their families
I. Dicle Sargin, Y. Gokdemir, R. Ersu, B. Karadag, P. Ay, A. Topuzoglu, C. Cimsit, F. Karakoc (Istanbul, Turkey)
Source:
Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Session:
Cystic fibrosis: clinical and laboratory studies
Session type:
Thematic Poster Session
Number:
4302
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Dicle Sargin, Y. Gokdemir, R. Ersu, B. Karadag, P. Ay, A. Topuzoglu, C. Cimsit, F. Karakoc (Istanbul, Turkey). Evaluation of disease knowledge in children with cystic fibrosis and their families. Eur Respir J 2011; 38: Suppl. 55, 4302
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Progression of lung disease detected by MRI and impact of NBS in preschool children with cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Early renal involvement in children with cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Identifying undiagnosed cystic fibrosis in adults with bronchiectasis
Source: Eur Respir Monogr 2018; 81: 29-44
Year: 2018
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021
Ergospirometry in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003
Prevalence of tracheobronchomalacia in young children with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019
Year: 2020
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
Source: ERJ Open Res, 6 (3) 00294-2019; 10.1183/23120541.00294-2019
Year: 2020
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Polysomnograpgic findings in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 391s
Year: 2003
Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005
Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002
Questions of predicting and preventing the progression of pneumofibrosis in children with cystic fibrosis
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings
Year: 2013
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis
Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept